Skip to main content
. 2024 Jan 16;38(4):741–750. doi: 10.1038/s41375-024-02136-7

Fig. 5. Inflammatory signaling in human CD34 HSPCs following human AML-derived EVAML exposure.

Fig. 5

A Schematic of hEVAML challenge on BM CD34 cells ex vivo. B Averaged gene expression analysis of CD34 cells following MOLM-14- (n = 4), HL-60- (n = 4), and U-937-(n = 4) hEVAML. C Venn diagram of the inflammatory gene expression profile in HSPCs challenged with different hEVAML. Statistical significance calculated using ANOVA. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.